ALX Oncology (ALXO) PT Raised to $100 at Credit Suisse
Tweet
Share
E-mail
Get Alerts ALXO Hot Sheet
Price: $2.03 -2.4%
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Join SI Premium – FREE
Credit Suisse analyst Tiago Fauth raised the price target on ALX Oncology (NASDAQ: ALXO) to $100.00 (from $98.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ALX Oncology to Present at Upcoming Investor Conferences in September
- Strike Co Ltd (6196:JP) PT Raised to JPY555 at Macquarie
- CLSA Downgrades Jiangsu Yanghe Brewery (002304:CH) to Hold (3)
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
